Reifenstein Dialysis Center in Juneau, Alaska - Dialysis Center

Reifenstein Dialysis Center is a medicare approved dialysis facility center in Juneau, Alaska and it has 9 dialysis stations. It is located in Juneau county at 9109 Mendenhall Mall Rd Suite #6, Juneau, AK, 99801. You can reach out to the office of Reifenstein Dialysis Center at (907) 790-3002. This dialysis clinic is managed and/or owned by Renal Care Group Inc.. Reifenstein Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 2004. The medicare id for this facility is 022504 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameReifenstein Dialysis Center
Location9109 Mendenhall Mall Rd Suite #6, Juneau, Alaska
No. of Dialysis Stations 9
Medicare ID022504
Managed ByRenal Care Group Inc.
Ownership TypeProfit
Late Shifts No

Contact Information


9109 Mendenhall Mall Rd Suite #6, Juneau, Alaska, 99801
(907) 790-3002

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Reifenstein Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1215049010
Doing Business AsDialysis Services Of Southeast Alaska, Llc
Address9109 Mendenhall Mall Rd Juneau, Alaska, 99801
Phone Number(907) 790-3002

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data13
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL8

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center22
    Adult patient months included in Kt/V greater than or equal to 1.2153
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center
  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center7
    Adult patient months included in Kt/V greater than or equal to 1.754
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Reifenstein Dialysis Center with elevated calcium levels.

Patients with hypercalcemia26
Hypercalcemia patient months214
Patients with Serumphosphor28
Patients with Serumphosphor less than 3.5 mg/dL4
Patients with Serumphosphor from 3.5 to 4.5 mg/dL15
Patients with Serumphosphor from 4.6 to 5.5 mg/dL21
Patients with Serumphosphor from 5.6 to 7 mg/dL37
Patients with Serumphosphor greater than 7 mg/dL23

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 29
Patient months included in arterial venous fistula and catheter summaries 145
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment66
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer3

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary23
Hospitalization Rate in facility109.2 (As Expected)
Hospitalization Rate: Upper Confidence Limit307
Hospitalization Rate: Lower Confidence Limit42.1

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Reifenstein Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility18.4 (As Expected)
Readmission Rate: Upper Confidence Limit54.5
Readmission Rate: Lower Confidence Limit2.7

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Reifenstein Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.73 (As Expected)
SIR: Upper Confidence Limit5.72
SIR: Lower Confidence Limit.29

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Reifenstein Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 22
Transfusion Rate in facility20.7 (As Expected)
Transfusion Rate: Upper Confidence Limit159
Transfusion Rate: Lower Confidence Limit3.5

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Reifenstein Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary104
Mortality Rate in facility27.1 (As Expected)
Mortality Rate: Upper Confidence Limit43.3
Mortality Rate: Lower Confidence Limit15.8

Dialysis Facility in Juneau, AK

Reifenstein Dialysis Center
Location: 9109 Mendenhall Mall Rd Suite #6, Juneau, Alaska, 99801
Phone: (907) 790-3002

Medicare Program: Medicare is a federal government program which provides health insurance to people who are 65 or older. This program also covers certain younger people with disabilities (who receive Social Security Disability Insurance - SSDI), and people with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant, sometimes called ESRD.

Medicare Assignment: Assignment means that your doctor, provider, or supplier agrees (or is required by law) to accept the Medicare-approved amount as full payment for covered services. Most doctors, providers, and suppliers accept assignment, but you should always check to make sure. Participating providers have signed an agreement to accept assignment for all Medicare-covered services.

NPI Number: The National Provider Identifier (NPI) is a unique identification number for covered health care providers. The NPI must be used in lieu of legacy provider identifiers in the HIPAA standards transactions. Covered health care providers and all health plans and health care clearinghouses must use the NPIs in the administrative and financial transactions adopted under HIPAA (Health Insurance Portability and Accountability Act).

Our Data: Information on www.medicarelist.com is built using data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA). The information disclosed on the NPI Registry are FOIA-disclosable and are required to be disclosed under the FOIA and the eFOIA amendments to the FOIA. There is no way to 'opt out' or 'suppress' the NPPES record data for health care providers with active NPIs.